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The increasing prevalence of asthma in children has 
become a significant health problem in most de-
veloped countries.1−3 Despite continuous efforts to 
develop highly effective drugs (including leuko-
triene antagonists and anti-IgE), therapies to “cure” 
allergic diseases once and for all are not currently 
available and strong concerns exist over the poten-
tial side effects caused by the long-term use of cur-
rently available drugs.4,5 Thus, effective remedies 
for the prevention and treatment of asthma are 
urgently needed by both doctors and patients. At 
the same time, an increasing number of patients are 
seeking alternative or complementary therapies.6−8 
Traditional Chinese medicine (TCM) is the common-
est form of complementary and alternative medi-
cine (CAM) worldwide. With increasing interest from 
the general population and more studies proving 
the efficacy of TCM for asthma, the US Food and 
Drug Administration issued the “Guidance for Industry 
Botanical Drug Products” in 2000. However, the lack 
of information regarding their clear functional mech-
anisms, the potential risks of drug interactions, and 
the lack of attention to unwanted side effects still 
cause major concerns over the use of TCM or CAM 
for asthma treatment.9,10
Asthma is a chronic inflammatory disorder char-
acterized by airway eosinophilia and remodeling, 
goblet cell hyperplasia, and airway hyperresponsive-
ness.11,12 Although the onset of asthma is attributed 
to both genetic and environmental factors, higher 
Th2-type activity is considered to be an important 
factor in the pathogenesis of asthma.13 Active Th2 
cell-secreted cytokines, such as interleukin (IL)-4 
and IL-5, are crucial for T cell differentiation into 
Th2 cells, for increased IgE production and for the 
development of eosinophilia in lung tissues.14−16 
During the past decade, some studies have demon-
strated the potential efficacy of TCM in asthma, 
including the use of classical formulae,17−19 newly 
established remedies,20,21 and single herbs.22,23 
Some reports have also focused on the modulation 
of Th1-Th2 responses.24,25 However, the effects of 
TCM on the interactions between T cells, epithelial 
cells and eosinophils have seldom been studied. 
In this issue of the Journal, Chiu et al26 report that 
osthol, a major component of Cnidii Monnieri Fructus 
extract, had a suppressive effect on IL-4-induced 
eotaxin production by BEAS-2B cells. Reduced levels 
of eotaxin were also detected even after stronger 
stimulation with a combination of IL-4 and tumor 
necrosis factor (TNF)-α. Furthermore, the authors 
demonstrated that the suppressive effect of osthol 
on the production of eotaxin was mediated via in-
hibition of phosphorylation of STAT-6. The molecules 
in the mitogen-activated protein kinase signaling 
pathway, however, were not significantly affected. 
Thus, the authors hypothesized that osthol might 
be a potentially useful agent for asthma treatment 
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due to its inhibition of eotaxin and downregulation 
of STAT-6.
Many issues need to be clarified to aid the fur-
ther development of osthol as an effective medicine. 
Firstly, detailed studies are needed to determine 
how osthol modulates the activation of the IL-4R-
JAK-STAT-6 pathway. Whether or not osthol has sim-
ilar effects on primary epithelial cells and in animal 
models of allergen-induced asthma also needs to be 
established. Most importantly, the potential toxici-
ties and side effects of osthol need to be carefully 
evaluated, particularly in asthmatic patients, and 
the potential risk of drug interactions between osthol 
and commonly prescribed asthma medicines should 
not be ignored. Nevertheless, the gap between TCM 
or compound(s) from herbal extracts and scientific 
mechanism-based medicine will be narrowed by in-
vestigation into these mechanisms, the identifica-
tion of the active ingredients, and by well-designed, 
randomized controlled trials. With the advantages 
of more advanced equipment in many research in-
stitutes and the availability of modern molecular 
and chemical techniques, clinical scientists now 
have great opportunities to mine the gold out of 
old wisdoms.
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